Towards Healthcare
Predictive Disease Analytics Market to Grow at 22.75% CAGR till 2034

Predictive Disease Analytics Market Expanding with Cloud Growth

Projections indicate that, predictive disease analytics industry is projected to rise from USD 3.12 billion in 2024 to USD 24.23 billion by 2034, reflecting a CAGR of 22.75% over the next decade. The predictive analytics majorly contributes to improving patient outcomes, enhancing public health and resource management, and reducing healthcare costs. North America dominated the market in 2024, driven by the widespread adoption of electronic health records, a focus on value-based patient care, and a high prevalence of chronic diseases.

  • Last Updated: 15 October 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

FAQ's

The predictive disease analytics market holds a valuation of USD 3.83 billion as of 2025, and will expand to USD 24.23 billion by 2034, achieving a CAGR of 22.75% between 2024 and 2034.

North America is currently leading the predictive disease analytics market due to the integration of big data, IoT, AI, ML, and cloud-based solutions, support for health IT, and a regulatory framework.

Some key players include Microsoft Healthcare, Google Health, Oracle Health, IBM Watson Health, Optum, etc.

CDC, HHS, AIIMS, WHO, EU, FDA.